Results 31 to 40 of about 1,712,671 (325)

Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma

open access: yesKerala Journal of Ophthalmology, 2016
Hepatitis C virus (HCV) is a blood-borne RNA virus that causes hepatitis C, chronic liver disease, and hepatocellular carcinoma. Patients with HCV infection are now treated with a combination of interferon alpha, which has antiviral and immunomodulatory ...
Prajina Rahul   +4 more
doaj   +1 more source

Hepatitis C virus genotypes in liver transplant recipients: Impact on posttransplant recurrence, infections, response to interferon-α therapy and outcome [PDF]

open access: yes, 1997
Background. End-stage liver disease due to hepatitis C virus (HCV) is the most common indication for liver transplantation in U.S. veterans. We investigated the influence of HCV genotypes on the incidence and timing of recurrent HCV hepatitis, survival ...
Fung, JJ   +10 more
core   +1 more source

INTERFERON-ALPHA-INDUCED DEMANTIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Interferon (IFN) treatment can produce side effects in the central nervous system. In this case report, a case of IFN-alphainduced dementia is reported and subject is reviewed.
Ali Ceran, Özcan Uzun, Salih Battal
doaj  

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment

open access: yesIndian Journal of Pathology and Microbiology, 2011
Background: Pegylated interferon and ribavirin combination therapy remain the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the large number of studies in treatment-naive patients, the effectiveness of retreatment in ...
Sila Cetin Akhan   +2 more
doaj   +1 more source

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection

open access: yesActa Dermato-Venereologica, 2023
Mycosis fungoides and Sézary syndrome are rare and largely incurable types of cutaneous T-cell lymphoma with limited therapeutic options. In 1984 Bunn et al.
Janika Gosmann   +4 more
doaj   +1 more source

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin. [PDF]

open access: yesEgyptian Journal of Medical Research, 2020
Background: Chronic Hepatitis C is common problem worldwide treated by combination of interferon alpha and ribavirin. Retinopathy is one of the side effects of interferon therapy.
Mansour Hassan   +3 more
doaj   +1 more source

Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment

open access: yesScientifica, 2014
Human interferon alpha (hIFNα) is a wide biological activity cytokine that is used in hepatitis and cancer treatments. It regulates many genes that are involved in antiviral and antiproliferative activities.
Ratih Asmana Ningrum
semanticscholar   +1 more source

Interferon Alpha Association with Neuromyelitis Optica

open access: yesClinical and Developmental Immunology, 2013
Interferon-alpha (IFN-α) has immunoregulatory functions in autoimmune inflammatory diseases. The goal of this study was to determine occurrence and clinical consequences of IFN-α in neuromyelitis optica (NMO) patients.
Nasrin Asgari   +5 more
doaj   +1 more source

Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer. [PDF]

open access: yes, 2016
Renal cell carcinoma (RCC) is increasing in incidence, and a complete cure remains elusive. While immune-checkpoint antibodies are promising, interferon-based immunotherapy has been disappointing.
Abu Aboud, Omran   +13 more
core   +2 more sources

Apoptosis in the lungs of pigs infected with porcine reproductive and respiratory syndrome virus and associations with the production of apoptogenic cytokines [PDF]

open access: yes, 2003
International audienceApoptosis was studied in the lungs of pigs during an infection with a European strain of porcine reproductive and respiratory syndrome virus (PRRSV) and it was examined if cytokines were involved in the induction of apoptosis ...
Labarque, Geoffrey   +4 more
core   +3 more sources

Home - About - Disclaimer - Privacy